Okyo Pharma Limited ADR (OKYO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.3500 +0.0900 (+7.14%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.3900 +0.0400 (+2.96%) 19:54 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2024 | 03-2023 | 03-2022 | 03-2021 | 03-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 827 | 4,045 | 2,701 | 6,889 | N/A |
| Receivables | 711 | 1,151 | 1,595 | 97 | N/A |
| TOTAL | $1,538 | $5,197 | $4,295 | $6,987 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 3 | 7 | 5 | 6 | N/A |
| Other Non-Current Assets | 0 | 0 | 0 | 99 | 0 |
| TOTAL | $3 | $7 | $5 | $105 | $N/A |
| Total Assets | $1,541 | $5,204 | $4,301 | $7,091 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 2,215 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 7,421 | 5,042 | 1,353 | 1,673 | 0 |
| TOTAL | $7,421 | $7,257 | $1,353 | $1,707 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $65 | $N/A |
| Total Liabilities | $7,421 | $7,257 | $1,353 | $1,772 | $N/A |
| Shareholders' Equity | |||||
| Retained earnings | -142,523 | -125,698 | -112,426 | -106,004 | N/A |
| Other shareholders' equity | -6,469 | -7,741 | -8,603 | -306 | 0 |
| TOTAL | $-5,880 | $-2,053 | $2,947 | $5,319 | $N/A |
| Total Liabilities And Equity | $1,541 | $5,204 | $4,301 | $7,091 | $0 |